Thierry D' Amato, MD, PhD
- 2Articles
- 14.6KReads1
- 2019Active
- 47Collaborators
- 69Citations2
About
Thierry D'Amato, MD, PhD, has published research on the prevalence and risk factors of metabolic syndrome in individuals with treatment-resistant depression, as well as on extrapyramidal side effects associated with antipsychotic use. The work focuses on clinical aspects of major depressive disorder and neurology. D'Amato's contributions appeared in Psychiatrist.com in 2019, often collaborating with colleagues including Bruno Aouizerate and Christophe Lancon.
Publications
Metabolic Syndrome in Treatment-Resistant Depression
October 15, 2019
1 Read counts for articles published before 2020 may include some non-human traffic.
2 Citation counts provided by Crossref.
Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.
